ANXA2 and cancer: This post-translational modification at Tyr24 is of particular interest in malignancy due to the early discovery of phosphorylated Annexin A2 in transformed cells (72, 73) and more recent observations of increased Tyr24 phosphorylation levels in cancer (74).